Canada Viral Capsid Development Market Size & Outlook

The viral capsid development market in Canada is expected to reach a projected revenue of US$ 23.4 million by 2033. A compound annual growth rate of 9.2% is expected of Canada viral capsid development market from 2026 to 2033.
Revenue, 2025 (US$M)
$11.6
Forecast, 2033 (US$M)
$23.4
CAGR, 2026 - 2033
9.2%
Report Coverage
Canada

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada viral capsid development market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Canada viral capsid development market highlights

  • The Canada viral capsid development market generated a revenue of USD 11.6 million in 2025 and is expected to reach USD 23.4 million by 2033.
  • The Canada market is expected to grow at a CAGR of 9.2% from 2026 to 2033.
  • In terms of segment, adeno-associated virus (aav) capsids was the largest revenue generating type in 2025.
  • Adeno-Associated Virus (AAV) Capsids is the most lucrative type segment registering the fastest growth during the forecast period.


Viral capsid development market data book summary

Market revenue in 2025USD 11.6 million
Market revenue in 2033USD 23.4 million
Growth rate9.2% (CAGR from 2026 to 2033)
Largest segmentAdeno-associated virus (aav) capsids
Fastest growing segmentAdeno-Associated Virus (AAV) Capsids
Historical data2021 - 2024
Base year2025
Forecast period2026 - 2033
Quantitative unitsRevenue in USD million
Market segmentationAdeno-Associated Virus (AAV) Capsids, Adenoviral, Lentiviral


Other key industry trends

  • In terms of revenue, Canada accounted for 3.7% of the global viral capsid development market in 2025.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
  • In North America, U.S. viral capsid development market is projected to lead the regional market in terms of revenue in 2033.
  • U.S. is the fastest growing regional market in North America and is projected to reach USD 291.6 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Viral Capsid Development Market Companies

Name Profile # Employees HQ Website
Capsigen View profile 11-50 Vancouver, British Columbia, Canada, North America https://capsigen.com/
Vigene Biosciences View profile 51-100 Rockville, Maryland, United States, North America https://www.vigenebio.com
Voyager Therapeutics View profile 101-250 Cambridge, Massachusetts, United States, North America https://www.voyagertherapeutics.com/
AAVnerGene View profile 1-10 Rockville, Maryland, United States, North America https://aavnergene.com
VectorBuilder View profile 501-1000 Chicago, Illinois, United States, North America https://www.vectorbuilder.com
PackGene Biotech View profile 251-500 Houston, Texas, United States, North America https://www.packgene.com
UniQure NV View profile 480 Paasheuvelweg 25, Amsterdam, NH, Netherlands, 1105 BP https://www.uniqure.com
Revvity Inc View profile 11500 940 Winter Street, Waltham, MA, United States, 02451 https://www.revvity.com
Sartorius AG View profile 14338 Otto-Brenner-Strasse 20, Gottingen, NI, Germany, 37079 https://www.sartorius.com

Canada viral capsid development market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to viral capsid development market will help companies and investors design strategic landscapes.


Adeno-associated virus (aav) capsids was the largest segment with a revenue share of 44.83% in 2025. Horizon Databook has segmented the Canada viral capsid development market based on adeno-associated virus (aav) capsids, adenoviral, lentiviral covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Canada viral capsid development market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Canada viral capsid development market databook

  • Our clientele includes a mix of viral capsid development market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Canada viral capsid development market , including forecasts for subscribers. This country databook contains high-level insights into Canada viral capsid development market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Canada viral capsid development market size, by type, 2021-2033 (US$M)

Canada Viral Capsid Development Market Outlook Share, 2025 & 2033 (US$M)

Canada viral capsid development market size, by type, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online